Raju Prasad

Stock Analyst at William Blair

(0)
# 4352
Out of 5,319 analysts
19
Total ratings
27.27%
Success rate
-14.67%
Average return
14 Stocks
Name Action Price Target Current % Upside Ratings Updated
PSTX Poseida Therapeutics
Downgrades: Market Perform
n/a
n/a n/a 1 Nov 26, 2024
DTIL Precision BioScience...
Downgrades: Market Perform
n/a
n/a n/a 1 Jun 9, 2022
NTLA Intellia Therapeutic...
Initiates Coverage On: Outperform
n/a
n/a n/a 1 Feb 18, 2022
LOGC LogicBio Therapeutic...
Downgrades: Market Perform
n/a
n/a n/a 1 Feb 3, 2022
GBT Global Blood Therape...
Upgrades: Outperform
n/a
n/a n/a 2 Dec 7, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 1 Sep 2, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
92
4.59 1904.36% 1 Jul 12, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Outperform
n/a
n/a n/a 3 Mar 12, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
46
1.24 3609.68% 1 Feb 24, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
45
0.39 11438.46% 1 Feb 24, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Market Perform
n/a
n/a n/a 1 Mar 14, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 2 Nov 7, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Outperform
n/a
n/a n/a 2 Jun 18, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
n/a
n/a n/a 1 Aug 23, 2017